Cvi Holdings, LLC has filed its 13F form on August 15, 2024 for Q2 2024 where it was disclosed a total value porftolio of $11.5 Million distributed in 144 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Inmune Bio, Inc. with a value of $5.26M, Azz Inc with a value of $3.18M, Regulus Therapeutics Inc. with a value of $717K, Protara Therapeutics, Inc. with a value of $629K, and Bio Line Rx Ltd. with a value of $464K.

Examining the 13F form we can see an decrease of $1.91M in the current position value, from $13.4M to 11.5M.

Cvi Holdings, LLC is based out at Wilmington, DE

Below you can find more details about Cvi Holdings, LLC portfolio as well as his latest detailed transactions.

Portfolio value $11.5 Million
Healthcare: $7.26 Million
Industrials: $3.18 Million
ETFs: $397,000
Basic Materials: $352,000
Financial Services: $53,000
Technology: $7,000

Stock Holdings Table Market Cap. of $50 Millions to $300 Millions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 144
  • Current Value $11.5 Million
  • Prior Value $13.4 Million
  • Filing
  • Period Q2 2024
  • Filing Date August 15, 2024
  • Form Type 13F-HR
  • Activity in Q2 2024
  • New Purchases 32 stocks
  • Additional Purchases 1 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 48 stocks
Track This Portfolio

Track Cvi Holdings, LLC Portfolio

Follow Cvi Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cvi Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cvi Holdings, LLC with notifications on news.